Sun Genomics gathers $9.25m Series A
Sun Genomics, a direct-to-consumer custom probiotics and gut health company, has raised $9.25 million in Series A funding.
Sun Genomics, a direct-to-consumer custom probiotics and gut health company, has raised $9.25 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination